Vera Therapeutics Inc - Ordinary Shares - Class A
VERA
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.36B
Close$
$4.32
85.1% downside
Current Fair Value
85.1% downsideOvervalued by 85.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.36 Billion |
|---|---|
| Enterprise Value | $2.39 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.66 |
| Beta | 0.92 |
| Outstanding Shares | 71,476,595 |
Return
| Return on Equity | -98.56% |
|---|---|
| Return on Assets | -75.40% |
| Return on Invested Capital | -82.98% |
Valuation & Multiples
| P/E Ratio | -5.94 |
|---|---|
| PEG | -13.79 |
| Price to Sales | - |
| Price to Book Ratio | 5.78 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.94 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-1.58
Average shareholder expectationRevenue Estimate
$1.28 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-1.71
Average shareholder expectationRevenue Estimate
$4.28 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 8.34% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | 127▼ 99.85% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 19.99%▼ 81.07% |
|---|---|
| Total Invested | $613.24M▼ 78.99% |
| Investors Holding | 58▼ 180.00% |
ESG Score
No data
About Vera Therapeutics Inc
19 employees